Cite
HARVARD Citation
McBride, A. et al. (2015). Carfilzomib: A second-generation proteasome inhibitor for the treatment of multiple myeloma. American journal of health-system pharmacy. pp. 353-360. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
McBride, A. et al. (2015). Carfilzomib: A second-generation proteasome inhibitor for the treatment of multiple myeloma. American journal of health-system pharmacy. pp. 353-360. [Online].